Metin Okşul

Metin Okşul

Auto-generated profile, based on publicly available information

Metin Okşul

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, KARDİYOLOJİ ANABİLİM DALI

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2022 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
EBErkan Baysal
Erkan Baysal
MOMetin Okşul
Metin Okşul
CBCengiz Burak
Cengiz Burak
KYKivanc YALIN
Kivanc YALIN
ASAli Ugur Soysal
Ali Ugur Soysal
TATolga Aksu
Tolga Aksu

19 July 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
SSSerdar Söner
Serdar Söner
TGTuncay Güzel
Tuncay Güzel
AAAdem Aktan
Adem Aktan
RKRaif Kılıç
Raif Kılıç
HSHülya Tosun Söner
Hülya Tosun Söner
FEFaruk Ertaş
Faruk Ertaş
The relationship between hemoglobin, albumin, lymphocyte, platelet (HALP) score, and various cancers and cardiovascular diseases has been tested previously. However, the relationship between HALP score and non-valvular atrial fibrillation (NVAF) has not been adequately tested. Therefore, our study aimed to investigate the relationship between HALP score and mortality in patients with NVAF. This study included 2,592 NVAF patients from 35 centers in Turkey. Patients were divided into two groups: those with HALP scores ≤ 58.96 (low HALP score group, 1,296 patients) and > 58.96 (high HALP score group, 1,296 patients). The primary outcome measured was all-cause mortality. The mean HALP score was 66 ± 33. Patients in the low HALP score group had higher 1- and 5-year all-cause mortality rates (1-year: 12.9% vs. 5.4%, p < 0.001; 5-year: 38.5% vs. 20.2%, p < 0.001). Cox regression analysis identified the HALP score as an independent predictor of mortality (1-year: HR = 0.987, 95% CI = 0.981-0.992, p < 0.001; 5-year: HR = 0.990, 95% CI = 0.987-0.993, p < 0.001). ROC analysis determined a HALP score 52.3 predicted 1-year mortality with 62.9% sensitivity and 62% specificity (AUC = 0.680); a score of 55 predicted 5-year mortality with 60.3% sensitivity and 62.2% specificity (AUC = 0.657). Kaplan-Meier analysis revealed increasing mortality over time in the low HALP score group (log-rank tests, 1-year = 44.86, p < 0.001; 5-year = 108.54, p < 0.001). The HALP score is a simple, accessible measure, and our findings suggest that lower HALP scores are associated with increased 1-year and 5-year mortality in NVAF patients. This provides a reference for clinicians assessing risk in this vulnerable population.

20 January 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
SSSerdar Söner
Serdar Söner
AAAdem Aktan
Adem Aktan
RKRaif Kılıç
Raif Kılıç
HGHamdullah Güzel
Hamdullah Güzel
ETErcan Taştan
Ercan Taştan
TGTuncay Güzel
Tuncay Güzel
The triglyceride glucose (TyG) index is a biomarker of insulin resistance and is associated with an increased risk of cardiovascular events. Contrast-induced nephropathy (CIN) is an important complication that causes poor outcomes in patients undergoing percutaneous coronary intervention (PCI). In this study, we aimed to investigate the relationship between the TyG index and CIN and mortality in patients who underwent PCI due to chronic total coronary occlusion (CTO). Two hundred eighteen individuals from three separate medical centers who underwent procedural PCI between February 2010 and April 2012 and had a CTO lesion in at least one coronary artery were recruited. According to the TyG index, patients were divided into two groups. Patients with a TyG index ≥ 8.65 were included in Group 1, and patients with a TyG index < 8.65 were included in Group 2. Patients were followed up for 96 months. The main outcome was the development of CIN and mortality. The mean age of the patients (65.8 ± 10.94 vs. 61.68 ± 11.4, P = 0.009), diabetes mellitus (60 [44.8%] vs. 11 [13.1%], P < 0.001), and dyslipidemia rates (52 [38.8%] vs. 21 [25%], P = 0.036) were higher in group 1. In multivariable logistic regression analysis, it was seen that age (OR = 1.04, 95% CI = 1.01–1.08, P = 0.020), chronic kidney disease (OR = 2.34, 95% CI = 1.02–5.33, P = 0.044), peripheral artery disease (OR = 5.66, 95% CI = 1.24–25.91, p = 0.026), LVEF (OR = 0.95, 95% CI = 0.92–0.99, P = 0.005), LDL cholesterol levels (OR = 1.00, 95%CI = 1.00–1.02, P = 0.024) and TyG index (OR = 2.17, 95% CI = 1.21–3.89, P = 0.009) were independent predictors of the development of CIN. Our study demonstrates a correlation between the TyG index and the prevalence of CIN in patients with CTO undergoing PCI. Adding the TyG index to the routine clinical evaluation of patients with CTO undergoing PCI may help protect patients from the development of CIN.

8 January 2020 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
PDF file
Yusuf Ziya ŞenerYusuf Ziya Şener
Yusuf Ziya Şener
MOMetin Okşul
Metin Okşul
Click on the article title to read more.

16 August 2022 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
MOMetin Okşul
Metin Okşul
Yusuf Ziya ŞenerYusuf Ziya Şener
Yusuf Ziya Şener
YSYasin Sarıkaya
Yasin Sarıkaya
SSSevtap Sarıkaya
Sevtap Sarıkaya
AYArzu Yıldırım
Arzu Yıldırım
LTLale TOKGÖZOĞLU
Lale TOKGÖZOĞLU

28 October 2021 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
CÇCem Çöteli
Cem Çöteli
MDMuhammet Dural
Muhammet Dural
Yusuf Ziya ŞenerYusuf Ziya Şener
Yusuf Ziya Şener
AAAhmet Hakan Ateş
Ahmet Hakan Ateş
MOMetin Okşul
Metin Okşul
KAKudret Aytemir
Kudret Aytemir